The work done by Northwestern University Feinberg School of Medicine faculty members (and even some students) is regularly highlighted in newspapers, online media outlets and more. Below you’ll find links to articles and videos of Feinberg in the news.
Along with that delay, the drug slowed down patients’ pain progression. “Delaying the cancer from growing is meaningful,” said Dr. Maha Hussain, who led the trial, which was funded by drug makers Astra Zeneca and Merck. “At the end of the day, patients want to live longer, and also better,” added Hussain, a professor at Northwestern University Feinberg School of Medicine, in Chicago. She was to present the findings Monday at the annual meeting of the European Society for Medical Oncology, in Barcelona. Studies reported at meetings are generally considered preliminary until they are published in a peer-reviewed journal.